Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Debt / NOTE 0.125%12/1
-
Unit price / market price
-
$0.9350
-
Total 13F principal
-
$113,009,000
-
Principal change
-
-$404,381,516
-
Total reported value
-
$105,739,050
-
Number of holders
-
27
-
Value change
-
-$374,542,371
-
Number of buys
-
5
-
Number of sells
-
25
Institutional Holders of IONIS PHARMACEUTICALS INC - NOTE 0.125%12/1 as of Q2 2023
As of 30 Jun 2023 IONIS PHARMACEUTICALS INC - NOTE 0.125%12/1 had 27 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $113,009,000 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included Sonora Investment Management Group, LLC, MORGAN STANLEY, Thrivent Financial for Lutherans, LAZARD ASSET MANAGEMENT LLC, STATE STREET CORP, OAKTREE CAPITAL MANAGEMENT LP, III Capital Management, Voya Investment Management LLC, PALISADE CAPITAL MANAGEMENT, LP, and Royal Bank of Canada.
This table shows 27 bond principal holders of the security as of 30 Jun 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.